Trial · NCT01467076
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Feasibility Assessed as the Number of Participants Who Were Enrolled in the Study | Control | 3 | participants | ||
| Feasibility Assessed as the Number of Participants Who Were Enrolled in the Study | Low Dose IPGE1 | 2 | participants | ||
| Feasibility Assessed as the Number of Participants Who Were Enrolled in the Study | High Dose IPGE1 | 2 | participants | ||
| Change in Partial Pressure of Oxygen in the Blood (PaO2) | Control | 30 | Full Range -1 to 59 | mmHg | |
| Change in Partial Pressure of Oxygen in the Blood (PaO2) | Low Dose IPGE1 | 85 | Full Range 22 to 148 | mmHg | |
| Change in Partial Pressure of Oxygen in the Blood (PaO2) | High Dose IPGE1 | 48 | Full Range -9 to 95 | mmHg | |
| Change in Oxygenation Index (OI) | Control | 4 | Full Range -1 to 9 | oxygenation index | |
| Change in Oxygenation Index (OI) | Low Dose IPGE1 | 14 | Full Range 6 to 21 | oxygenation index | |
| Change in Oxygenation Index (OI) | High Dose IPGE1 | 10 | Full Range -5 to 25 | oxygenation index | |
| Need for Inhaled Nitric Oxide (INO) 72 Hours After INO | Control | 1 | Participants | ||
| Need for Inhaled Nitric Oxide (INO) 72 Hours After INO | Low Dose IPGE1 | 0 | Participants | ||
| Need for Inhaled Nitric Oxide (INO) 72 Hours After INO | High Dose IPGE1 | 0 | Participants | ||
| Duration of iNO Therapy | Control | 59.02 | Full Range 44.95 to 73.08 | hours | |
| Duration of iNO Therapy | Low Dose IPGE1 | 18.57 | Full Range 18.57 to 18.57 | hours | |
| Duration of iNO Therapy | High Dose IPGE1 | 56.22 | Full Range 50.35 to 62.08 | hours | |
| Death | Control | 0 | Participants | ||
| Death | Low Dose IPGE1 | 0 | Participants | ||
| Death | High Dose IPGE1 | 0 | Participants | ||
| Need for Extracorporeal Membrane Oxygenation (ECMO) | Control | 2 | Participants | ||
| Need for Extracorporeal Membrane Oxygenation (ECMO) | Low Dose IPGE1 | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01467076/results